| Type | Title | Date Released | |
|---|---|---|---|
8-K | SRX Global Inc. Enters Into Stock Purchase Agreement to Acquire CERo Therapeutics, Inc. | ||
8-K | SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through EMJX Platform | ||
8-K | SRX Global Inc. Enters into Limited Consent and Amendment Agreement for Stock Repurchase Plan | ||
8-K | SRX Global Inc. Enters into Secured Financing Transaction with CERo Therapeutics Holdings, Inc. | ||
8-K | SRX Global Inc. Announces Private Placement of Series C Convertible Preferred Stock | ||
8-K | SRX Global Inc. Reports Fiscal Third Quarter 2026 Financial Results and Strategic Updates | ||
10-Q | Form 10-Q | ||
8-K/A | Amended Report Corrects CEO Identification Error; Additional Private Placement Raises $3.472 Million Through Series B Preferred Stock Sale. | ||
8-K | SRX Global Inc. Completes Additional Closing of Private Placement | ||
8-K | SRX Global Inc. Secures Waiver for Dividend Payment and Stock Repurchase Plan | ||
424B3 | SHARE RESALE REGISTRATION | Shares: 3,125,752 | ||
424B3 | SHARE RESALE REGISTRATION | Shares: 41,781,566 |
